Episode 1 of 2: Talk to Me About Dual Agonists

Course Description

For prescribers and non-prescribers alike, therapeutic inertia can be a big challenge when trying to optimize therapy to control patients’ glucose levels and improve their overall health. Such obstacles can be even more difficult when trying to switch treatment regimens. Novel therapies can be miracles, but only if patients can actually get them. In Talk to Me About Dual Agonists, episode 1 of the Med Table TalkTM series, certified diabetes care and education specialists address therapeutic inertia and the need to treat the whole person, rather than just A1C. They then explain the mechanisms of action, efficacy and safety, and precautions for using a unimolecular dual agonist and strategies for helping patients gain access.

Scroll to Top